483
Onyx Pharmaceuticals, Inc.Onyx Pharmaceuticals, Inc. – FDA 483, Oct 8, 2002
Record Details
Onyx Pharmaceuticals, Inc. in Richmond, CA, was cited for significant deficiencies in its clinical trial oversight, specifically regarding the reporting and review of adverse events. The firm failed to report unexpected and serious adverse events within the required 15-day timeframe and inadequately reviewed safety reports. Additionally, the company did not conduct sufficient follow-ups to gather necessary information on serious adverse events, hindering proper reporting determinations.
View Company Profile
ID · b956851b-9c9a-4a99-b8a9-6e809cdd0aa2
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.